• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

VB Spine to Acquire CT-Fluoro Technology for Spine Applications from Augmedics

July 7, 2026 By SPINEMarketGroup

The company has entered a definitive agreement to acquire exclusive rights to Augmedics’ CT-to-fluoroscopy (CT-Fluoro) technology for Spine Applications

NEW YORK–(BUSINESS WIRE)–VB Spine LLC (“VB Spine”) today announced it has entered into a definitive agreement to acquire the exclusive rights to Augmedics’ CT-to-fluoroscopy (CT-Fluoro) technology for spine applications.

This acquisition reflects VB Spine’s ongoing investment in innovative technologies, building on the acquisition of exclusive rights to the Augmedics’ xvision Spine System® platform in April. With CT-Fluoro technology, surgeons are able to register a patient’s preoperative CT scan using standard fluoroscopic imaging, potentially eliminating the need for intraoperative CT or 3D imaging systems during spine procedures. By expanding workflow flexibility and reducing imaging requirements, CT-Fluoro technology helps make augmented reality navigation more accessible across a broader range of facilities and surgical settings.

“At VB Spine, our goal is to remove barriers that prevent surgeons from accessing technologies that improve procedural efficiency and patient care,” said Marc Viscogliosi, co-CEO of VB Spine, speaking on behalf of his brothers and fellow co-CEOs Anthony and John Viscogliosi. “The addition of CT-Fluoro technology for spine applications will be an important step forward for the xvision platform because it provides surgeons with greater flexibility in how they utilize navigation.”

The addition of CT-Fluoro technology further strengthens the xvision ecosystem and underscores VB Spine’s long-term commitment to investing in enabling technologies that simplify adoption, expand access, and keep patient outcomes at the center of innovation.

Following the closing of the transaction, VB Spine intends to make CT-Fluoro technology available as part of its technology offerings for spine procedures. The transaction is subject to customary closing conditions and regulatory requirements. Terms of the transaction were not disclosed.

Forward-looking statements

Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law.

About VB Spine

VB Spine LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. With a comprehensive portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. Focused on people, partnerships, and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit www.vbspineco.com.

Contacts

For media inquiries only:
spinecommunications@vbspineco.com

Related Posts:

  • VB Spine Announces Intent to Acquire Exclusive…
  • VB Spine Completes Transaction of Augmented Reality…
  • Augmedics Announces FDA Clearance, Completion of…

Filed Under: NEWS Tagged With: 2026

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical: Stronger in Spine, but Could DePuy…
  • BROCHURES
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Highridge Medical CEO Departure: Spine’s…
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Single-Use Spine Surgery Systems: The Future or…
  • Strong Surgery, Soft Quarter: ATEC and the Cost of…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • COMPANIES
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • Autonomous Pedicle Screw Placement: Is Spine…
  • PRODUCT LIBRARY
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • What Is Medtronic’s PILAR™ Technique?
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • Hospital Access Is Gone. What Comes Next for Spine…
  • VB Spine Announces VB Spine Solutions, a…
  • Johnson & Johnson Explores Potential $20B Sale…
  • Top 60+ Minimally Invasive Sacroiliac Joint Fusion…
  • Sublaminar Bands in Spine Surgery: Why This Small…
  • Percutaneous MIS Spine Systems: Why Adoption Still…
  • Globus Medical Reports First Quarter 2026 Results
  • L&K Spine Performs First U.S. Deformity Case…
  • VB Spine Signs Master Agreement with Apolo Medica
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • LAST 5 VIDEOS PUBLISHED

    1. Mighty Oak: Acorn 3D™
    2. Syntropiq: Lyra
    3. ATEC Spine: SafeOp®
    4. REACH Medical: Expandable PLIF/TLIF Cage
    5. Expanding Innovations: X-PAC®TLIF 

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup